AR015893A1 - Fragmento estructural derivado de oxietileno, derivados beta-amino y beta-azido de acido carbonico que lo comprenden, su uso para tratar enfermedades comoantagonistas de receptores de endotelina, composiciones farmaceuticas para administracion oral, parenteral e intraparenteral que lo comprenden, co - Google Patents
Fragmento estructural derivado de oxietileno, derivados beta-amino y beta-azido de acido carbonico que lo comprenden, su uso para tratar enfermedades comoantagonistas de receptores de endotelina, composiciones farmaceuticas para administracion oral, parenteral e intraparenteral que lo comprenden, coInfo
- Publication number
- AR015893A1 AR015893A1 ARP980102873A ARP980102873A AR015893A1 AR 015893 A1 AR015893 A1 AR 015893A1 AR P980102873 A ARP980102873 A AR P980102873A AR P980102873 A ARP980102873 A AR P980102873A AR 015893 A1 AR015893 A1 AR 015893A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- phenyl
- beta
- nitrogen
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
- C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
- C07C247/12—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
- C07D237/16—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/22—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to two ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19726146A DE19726146A1 (de) | 1997-06-19 | 1997-06-19 | Neue ß-Amino und ß-Azidopcarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR015893A1 true AR015893A1 (es) | 2001-05-30 |
Family
ID=7833081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980102873A AR015893A1 (es) | 1997-06-19 | 1998-06-17 | Fragmento estructural derivado de oxietileno, derivados beta-amino y beta-azido de acido carbonico que lo comprenden, su uso para tratar enfermedades comoantagonistas de receptores de endotelina, composiciones farmaceuticas para administracion oral, parenteral e intraparenteral que lo comprenden, co |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0994861A1 (xx) |
| JP (1) | JP2002504130A (xx) |
| KR (1) | KR20010013981A (xx) |
| CN (1) | CN1261352A (xx) |
| AR (1) | AR015893A1 (xx) |
| AU (1) | AU8213398A (xx) |
| BG (1) | BG104022A (xx) |
| BR (1) | BR9810182A (xx) |
| CA (1) | CA2294050A1 (xx) |
| CO (1) | CO4950605A1 (xx) |
| DE (1) | DE19726146A1 (xx) |
| HR (1) | HRP980331A2 (xx) |
| HU (1) | HUP0002714A3 (xx) |
| ID (1) | ID24346A (xx) |
| IL (1) | IL133104A0 (xx) |
| NO (1) | NO996268L (xx) |
| NZ (1) | NZ502319A (xx) |
| PL (1) | PL337507A1 (xx) |
| SK (1) | SK176299A3 (xx) |
| TR (1) | TR199903159T2 (xx) |
| WO (1) | WO1998058916A1 (xx) |
| ZA (1) | ZA985277B (xx) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19806438A1 (de) * | 1998-02-17 | 1999-08-19 | Basf Ag | Neue Carbonsäurederivate mit 5-substituiertem Pyrimidinring, ihre Herstellung und Verwendung |
| DE19858779A1 (de) * | 1998-12-18 | 2000-06-21 | Basf Ag | Neue ß-Amido und ß-Sulfonamidocarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
| DE19924892A1 (de) * | 1999-06-01 | 2000-12-07 | Basf Ag | Neue Carbonsäurederivate mit arylsubstituierten Stickstoffheterocyclen, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten |
| WO2002064573A1 (de) * | 2001-02-14 | 2002-08-22 | Abbott Gmbh & Co. Kg | Neue carbonsäurederivate mit alkylsubstituierten triazinen, ihre herstellung und verwendung als endothelin-rezeptorantagonisten |
| EP1632821B1 (en) | 2004-09-01 | 2012-05-30 | Océ-Technologies B.V. | Intermediate transfer member with a cleaning member |
| US7790770B2 (en) * | 2005-11-23 | 2010-09-07 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| MX2010001255A (es) | 2007-07-31 | 2010-12-06 | Gilead Colorado Inc | Metabolitos y derivados de ambrisentan. |
| CN109422664B (zh) * | 2017-08-23 | 2022-02-18 | 中国科学院福建物质结构研究所 | 一类干扰素调节剂及其制备方法和用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5136060A (en) * | 1989-11-14 | 1992-08-04 | Florida State University | Method for preparation of taxol using an oxazinone |
| DE4313412A1 (de) * | 1993-04-23 | 1994-10-27 | Basf Ag | 3-(Het)aryl-Carbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung |
| DE4329911A1 (de) * | 1993-09-04 | 1995-03-09 | Basf Ag | Substituierte Milchsäurederivate mit einem N-organischen Rest in beta-Position |
| DE4411225A1 (de) * | 1994-03-31 | 1995-10-05 | Basf Ag | Verwendung von Carbonsäurederivaten als Arzneimittel |
| DE19614533A1 (de) * | 1996-04-12 | 1997-10-16 | Basf Ag | Neue alpha-Hydroxysäurederivate, ihre Herstellung und Verwendung |
-
1997
- 1997-06-19 DE DE19726146A patent/DE19726146A1/de not_active Withdrawn
-
1998
- 1998-06-05 PL PL98337507A patent/PL337507A1/xx unknown
- 1998-06-05 CA CA002294050A patent/CA2294050A1/en not_active Abandoned
- 1998-06-05 BR BR9810182-0A patent/BR9810182A/pt not_active IP Right Cessation
- 1998-06-05 EP EP98932123A patent/EP0994861A1/de not_active Withdrawn
- 1998-06-05 HU HU0002714A patent/HUP0002714A3/hu unknown
- 1998-06-05 JP JP50366799A patent/JP2002504130A/ja active Pending
- 1998-06-05 KR KR19997012007A patent/KR20010013981A/ko not_active Application Discontinuation
- 1998-06-05 SK SK1762-99A patent/SK176299A3/sk unknown
- 1998-06-05 WO PCT/EP1998/003366 patent/WO1998058916A1/de not_active Application Discontinuation
- 1998-06-05 AU AU82133/98A patent/AU8213398A/en not_active Abandoned
- 1998-06-05 TR TR1999/03159T patent/TR199903159T2/xx unknown
- 1998-06-05 ID IDW991614A patent/ID24346A/id unknown
- 1998-06-05 CN CN98806397A patent/CN1261352A/zh active Pending
- 1998-06-05 NZ NZ502319A patent/NZ502319A/en unknown
- 1998-06-05 IL IL13310498A patent/IL133104A0/xx unknown
- 1998-06-17 AR ARP980102873A patent/AR015893A1/es unknown
- 1998-06-17 HR HR19726146.9A patent/HRP980331A2/hr not_active Application Discontinuation
- 1998-06-18 ZA ZA9805277A patent/ZA985277B/xx unknown
- 1998-06-18 CO CO98034781A patent/CO4950605A1/es unknown
-
1999
- 1999-12-16 BG BG104022A patent/BG104022A/xx unknown
- 1999-12-17 NO NO996268A patent/NO996268L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO996268D0 (no) | 1999-12-17 |
| JP2002504130A (ja) | 2002-02-05 |
| CN1261352A (zh) | 2000-07-26 |
| AU8213398A (en) | 1999-01-04 |
| HUP0002714A3 (en) | 2001-07-30 |
| NO996268L (no) | 1999-12-17 |
| ZA985277B (en) | 1999-12-20 |
| DE19726146A1 (de) | 1998-12-24 |
| BG104022A (en) | 2001-04-30 |
| HUP0002714A2 (hu) | 2001-05-28 |
| HRP980331A2 (en) | 1999-02-28 |
| CA2294050A1 (en) | 1998-12-30 |
| PL337507A1 (en) | 2000-08-28 |
| KR20010013981A (ko) | 2001-02-26 |
| NZ502319A (en) | 2002-03-01 |
| ID24346A (id) | 2000-07-13 |
| CO4950605A1 (es) | 2000-09-01 |
| TR199903159T2 (xx) | 2000-07-21 |
| WO1998058916A1 (de) | 1998-12-30 |
| SK176299A3 (en) | 2000-06-12 |
| BR9810182A (pt) | 2000-08-08 |
| EP0994861A1 (de) | 2000-04-26 |
| IL133104A0 (en) | 2001-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2100187T3 (es) | Derivados de carboestirilos y composiciones farmaceuticas que los contienen. | |
| MX165708B (es) | Composiciones de sales para explosivos | |
| PT1140851E (pt) | 4-oxo-1,4-di-hidro-3-quinolinacarboxamidas como agentes antivirais | |
| PE20020228A1 (es) | Compuestos organicos como inhibidores de 3',5' guanosin monofosfato ciclico fosfodiesterasa | |
| ES2061756T3 (es) | Complejos de platino (ii), su preparacion y uso como agentes anti-tumor. | |
| MX167174B (es) | Composiciones detergentes suavizadoras | |
| AR015893A1 (es) | Fragmento estructural derivado de oxietileno, derivados beta-amino y beta-azido de acido carbonico que lo comprenden, su uso para tratar enfermedades comoantagonistas de receptores de endotelina, composiciones farmaceuticas para administracion oral, parenteral e intraparenteral que lo comprenden, co | |
| MY106406A (en) | Acryloyl substituted pyrrole derivatives. | |
| ES2095942T3 (es) | Derivados de bencenoacetamida inhibidores del vih. | |
| PE58599A1 (es) | 2-amino-6-(4-fenoxi-2-sustituido)-piridinas sustituidas | |
| AR240941A2 (es) | Procedimiento para preparar compuestos de pirazolopirimidinas | |
| ES2072108T3 (es) | Procedimiento de tincion de fibras queratinicas que asocia isatina o uno de sus derivados a una aminopiridina o aminopirimidina, y agentes de tincion. | |
| CO5631434A2 (es) | Derivados de piridina-carboxamida y su uso como plaguicidas | |
| ES2026669T3 (es) | Procedimiento para la preparacion y el uso terapeutico de los beta-d-fenil tioxilosidos. | |
| CO4980887A1 (es) | Nueva 3,4-diariltiazolina-2-uno o 2-tiono derivados, sus metodos de preparacion y su uso terapeutico | |
| AR041786A1 (es) | Derivados de azetidina como antagonistas del receptor ccr-3, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la elaboracion de un medicamento | |
| AR017418A1 (es) | Una composicion acuosa bombeable y fluida, util como composicion surfactante concentrada y el proceso para prepararla | |
| AR035242A1 (es) | Uso de un lipido bioactivo halogenadopara preparar una composicion catartica y compuesto lipido bioactivo halogenado | |
| ES2117132T3 (es) | Sales de desferrioxamina-b y su uso como queladores de hierro eficaces por via oral. | |
| ES2056811T3 (es) | Derivados de cinolina, procedimiento para su preparacion y composiciones herbicidas que los contienen. | |
| CO4930270A1 (es) | Derivados heterociclicos de acido carbonico su produccion y aplicacion como antagonistas de receptores deendotelina | |
| ES2036583T3 (es) | Iminooxazolidinas, procedimiento de preparacion y metodo de uso. | |
| ES2108897T3 (es) | Compuesto del tipo oxima eter, procesos para su preparacion y fungicida que contiene dicho compuesto. | |
| AR017052A1 (es) | Derivados del acido carboxilico y su uso para preparar medicamentos. | |
| ES2170537T3 (es) | Composicion acuosa que neutraliza el fluoruro de amina para pretratamientos de metales que contienen una resina organica y procedimiento de pretratamiento de metales. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |